Rejuvenate Bio, Inc.
StreetZero Signal 66
About Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc. is a biotechnology company focused on pioneering gene therapy solutions to combat chronic diseases and the root causes of aging. The San Diego-based firm develops one-time gene therapies targeting aging and chronic conditions. Founded in 2019, it operates as a privately held company with a website at www.rejuvenatebio.com.
LATEST FUNDINGCrowdfunding
$5.0M
Announced 2026-11-02
TOTAL RAISED$28.57M
IN THE NEWS
- ๐ Rejuvenate Bio - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- ๐ Rejuvenate Bio, Inc. Asset Profile | Preqin | BlackRock
- ๐ Rejuvenate Bio Company Overview, Contact Details & Competitors | LeadIQ
- ๐ Rejuvenate Bio, Inc.
- ๐ Rejuvenate Bio Raises Over $10M in Series A Funding for Gene Therapy Aging Treatment โ Rejuvenate Bio
EMPLOYEESโ
FOUNDED2019
HQSan Diego, CA, US
Industry
Crowdfunding
Tags
BiotechnologyGene TherapyAging
Investors
Key highlights
- Raised over $10M in Series A led by Kendall Capital Partners with participation from KdT Ventures and others.
- Completed a $5M crowdfunding round with investors not disclosed.
- Total funding across rounds exceeds $28M from institutional and other backers.
- Developing gene therapies targeting chronic diseases and aging mechanisms.
Ask StreetZero about Rejuvenate Bio, Inc.
Put our AI to work on this deal.
Similar companies
Other Crowdfunding deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account